Login Register Cart 0
Biography

Meet the Regional Editor

Author(s): Anke van den Berg

Volume 12, Issue 1, 2023

Page: [2 - 2] Pages: 1

DOI: 10.2174/221153661201230206152903

« Previous Next »
[1]
Winkle M, Tayari MM, Kok K, et al. The lncRNA KTN1-AS1 co-regulates a variety of Myc-target genes and enhances proliferation of Burkitt lymphoma cells. Human Molecular Genetics 2022.
[2]
Placa JR, Diepstra A, Los T, et al. Reproducibility of Gene Expression Signatures in Diffuse Large B-Cell Lymphoma. Cancers 2022; 14(5)
[3]
Veldman J, Placa JR, Chong L, et al. CD4+ T cells in classical Hodgkin lymphoma express exhaustion associated transcription factors TOX and TOX2: Characterizing CD4+ T cells in Hodgkin lymphoma. OncoImmunology 2022; 11(1): 2033433.
[4]
Swier LJYM, Dzikiewicz-Krawczyk A, Winkle M, van den Berg A, Kluiver J. Intricate crosstalk between MYC and non-coding RNAs regulates hallmarks of cancer. Mol Oncol 2019; 13(1): 26-45.
[5]
Teteloshvili N, Dekkema G, Boots A, et al. Involvement of microRNAs in the aging-related decline of CD28 expression by human T cells. Front Immunol 2018; 9: 1400.
[6]
Yuan Y, Niu F, Nolte IM, et al. MicroRNA high throughput loss-of function screening reveals an oncogenic role for miR-21-5p in Hodgkin lymphoma. Cell Physiol Biochem 2018; 49: 144-59.
[7]
Hartleben G, Müller C, Krämer A, et al. TSC1 is required for tumor maintenance in MYC-driven Burkitt’s lymphoma. EMBO J 2018; 37(21): e98589.
[8]
Dzikiewicz-Krawczyk A, Diepstra A, Rutgers B, et al. Argonaute 2 RNA immunoprecipitation reveals distinct miRNA targetomes of primary Burkitt lymphoma tumors and normal B cells. Am J Pathol 2018; 188(5): 1289-99.

Rights & Permissions Print Cite
Article Metrics
13
2
© 2024 Bentham Science Publishers | Privacy Policy